145 related articles for article (PubMed ID: 35117496)
1. Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection.
Yu JH; Wang D; Jin L; Wang J; Zhao XM; Wu GC; Yao HW; Yang YC; Zhang ZT
Transl Cancer Res; 2020 Mar; 9(3):1487-1494. PubMed ID: 35117496
[TBL] [Abstract][Full Text] [Related]
2. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
3. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter
Jin L; Fan WH; Luan Y; Wu M; Zhao W
PeerJ; 2021; 9():e11366. PubMed ID: 33987029
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer.
Yu J; Bai Y; Jin L; Zhang Z; Yang Y
Ann Surg Oncol; 2023 Dec; 30(13):8495-8500. PubMed ID: 37598121
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer.
Chen L; Zhou W; Ye Z; Zhong X; Zhou J; Chen S; Liu W; Sun Y; Ren L; Tan X; Cui J; Zeng Z; He W; Ke Z
ACS Appl Mater Interfaces; 2022 Aug; 14(31):35389-35399. PubMed ID: 35904812
[TBL] [Abstract][Full Text] [Related]
8. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients.
Liu Z; Gu Y; Yu F; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Qian W; Li X
Evid Based Complement Alternat Med; 2022; 2022():4162354. PubMed ID: 36193123
[TBL] [Abstract][Full Text] [Related]
9. Combined Features Based on Preoperative Controlling Nutritional Status Score and Circulating Tumour Cell Status Predict Prognosis for Colorectal Cancer Patients Treated with Curative Resection.
Yang C; Wei C; Wang S; Han S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(6):1325-1335. PubMed ID: 31223290
[No Abstract] [Full Text] [Related]
10. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
12. Significant diagnostic value of circulating tumour cells in colorectal cancer.
Yu H; Ma L; Zhu Y; Li W; Ding L; Gao H
Oncol Lett; 2020 Jul; 20(1):317-325. PubMed ID: 32565958
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre- and post-operative circulating tumor cells detection in colorectal cancer patients treated with curative resection: a prospective cohort study based on ISET device.
Yang C; Shi D; Wang S; Wei C; Zhang C; Xiong B
Cancer Manag Res; 2018; 10():4135-4144. PubMed ID: 30323669
[TBL] [Abstract][Full Text] [Related]
14. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Circulating Tumor Cells in Prognosis of Stage III/IV Colorectal Cancer After Oxaliplatin-based First-line Chemotherapy.
Yu J; Zhang J; Peng T; Fei Z; Jin L; Yang M
In Vivo; 2022; 36(2):806-813. PubMed ID: 35241536
[TBL] [Abstract][Full Text] [Related]
18. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
